A review proposes that resistance evolves from early immune evasion through adaptive immunosuppression to advanced metastatic resistance with spatial heterogeneity. (Crit Rev Oncol Hematol)
Immunotherapy resistance in dMMR colorectal cancer follows evolutionary trajectory
The CRC Digest